Índia -
anglès -
Central Drugs Standard Control Organization
fentanor 3x1ml inj
samarth - phentolamine mesylate - inj - 10mg/ml - 3x1ml
Índia -
anglès -
Central Drugs Standard Control Organization
phentosol 3 inj
sg ph. - phentolamine mesylate - inj - 10mg/ml - 3
Austràlia -
anglès -
Department of Health (Therapeutic Goods Administration)
regitine 10mg/1ml injection ampoule
novartis pharmaceuticals australia pty ltd - phentolamine mesylate -
Regne Unit -
anglès -
myHealthbox
invicorp 25micrograms/2mg solution for injection
iwa consulting aps - aviptadil, phentolamine mesilate - solution for injection - 25micrograms/2mg - combined medicinal products in erectile dysfunction - it is indicated for the symptomatic treatment of erectile dysfunction in adult males due to neurogenic, vasculogenic, psychogenic, or mixed aetiology.
Irlanda -
anglès -
HPRA (Health Products Regulatory Authority)
tyvense 30 milligram capsules hard
shire pharmaceutical contracts ltd - lisdexamfetamine dimesylate - capsules hard - 30 milligram - 06ba12
Irlanda -
anglès -
HPRA (Health Products Regulatory Authority)
tyvense 70 milligram capsules hard
shire pharmaceutical contracts ltd - lisdexamfetamine dimesylate - capsules hard - 70 milligram - 06ba12
Irlanda -
anglès -
HPRA (Health Products Regulatory Authority)
tyvense 50 milligram capsules hard
shire pharmaceutical contracts ltd - lisdexamfetamine dimesylate - capsules hard - 50 milligram - 06ba12
Irlanda -
anglès -
HPRA (Health Products Regulatory Authority)
tyvense 20 milligram capsules hard
shire pharmaceutical contracts ltd - lisdexamfetamine dimesylate - capsules hard - 20 milligram - phenylethylamine derivatives - centrally acting sympathomimetics - it is indicated as part of a comprehensive treatment programme for attention deficit/hyperactivity disorder (adhd) in children aged 6 years and over when response to previous methylphenidate treatment is considered clinically inadequate
Irlanda -
anglès -
HPRA (Health Products Regulatory Authority)
tyvense 40 milligram capsules hard
shire pharmaceutical contracts ltd - lisdexamfetamine dimesylate - capsules hard - 40 milligram - phenylethylamine derivatives - centrally acting sympathomimetics - it is indicated as part of a comprehensive treatment programme for attention deficit/hyperactivity disorder (adhd) in children aged 6 years and over when response to previous methylphenidate treatment is considered clinically inadequate
Irlanda -
anglès -
HPRA (Health Products Regulatory Authority)
tyvense 60 milligram capsules hard
shire pharmaceutical contracts ltd - lisdexamfetamine dimesylate - capsules hard - 60 milligram - phenylethylamine derivatives - centrally acting sympathomimetics - it is indicated as part of a comprehensive treatment programme for attention deficit/hyperactivity disorder (adhd) in children aged 6 years and over when response to previous methylphenidate treatment is considered clinically inadequate.